C(2021) 8740(final) of 26 November 2021 amending the conditional marketing authorisation granted by Decision C(2020)
2021/3052(RSP)
Comirnaty Vaccine Authorisation
2022/2941(RSP)
Draft granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council
2022/2940(RSP)
Granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for
2022/2928(RSP)
The annual renewal of the conditional marketing authorisation for the medicinal product for human use "Veklury -
2022/2661(RSP)
Gardasil 9: Marketing Objection
2023/2623(RSP)
Paxlovid Marketing Objection
2023/2604(RSP)